A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.

@article{Lucey2005ACO,
  title={A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.},
  author={Michael R Lucey and Manal F. Abdelmalek and Rosemarie Gagliardi and Darla K Granger and Curtis D Holt and Igal Kam and Goran Klintmalm and Alan Langnas and K Sadashivas Shetty and Andreas Tzakis and E. Steve Woodle},
  journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
  year={2005},
  volume={5 5},
  pages={1111-9}
}
A retrospective chart review of 1065 consecutive liver allograft recipients in 11 centers from January 1997 to September 1998 was performed. Patients were followed for 3 years or until graft loss. Patients received either tacrolimus (n = 594), cyclosporine (n = 450) or no calcineurin inhibitor (n = 21). Model for end-stage liver disease (MELD) scores at time of transplant were similar between the two groups. During follow-up, more patients switched from cyclosporine to tacrolimus (26.7%) than… CONTINUE READING
28 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Similar Papers

Loading similar papers…